The Third Generation Sequencing Genome Center

Grandomics has been the third generation sequencing genome center with sequencing platforms of Oxford Nanopore, Pacbio Sequel and Bionano optical mapping imaging technology. Grandomics has fully launched the third-generation sequencing services in the field of genetic diseases, cancer and human microbiome , including whole genome sequencing,full-length transcriptome sequencing, whole genome methylation sequencing and so on, which offer the most comprehensive view of genomes, transcriptomes, and epigenomes — including the full spectrum of genetic variations.

Oxford Nanopore  PromethION

  • High-throughput, high-sample number benchtop system
  • Modular: Up to 48 flow cells, each with up to 3,000 nanopore channels (total up to 144,000)
  • Flow cells may be run individually or concurrently
  • Same workflow as MinION at larger scale,especially applicable to very large data volumes sequencing projects (Tb) with large numbers of samples

Oxford Nanopore GridION X5

  • Multiple sequencing devices, one compute module
  • Use up to five MinION Flow Cells at a time
  • Benchtop processor capable of handling high data volumes in real time,especially applicable tolarger sequencing projects (50–100Gb per 48 hrs)
  • Rapid, real-time applications

PacBio Sequel

  • Break the bottleneck of traditional short read sequencing technology

Bionano SaphyrTM  

  • A new generation of optical map imaging technology
  • Providing you with the “seeing is believing” genetic testing
  • In January 2016

    Grandomics introduced PacBio Sequel  sequencing platform

  • In March 2017

    Grandomics completed the construction of Beijing laboratory and held the launch ceremony of the world’s largest third-generation sequencing center (PacBio) , and became the world’s first third-generation sequencing genetic disease diagnosis company

  • In May 2017

    Grandomics introduced Bionano SaphyrTM  platform

  • In September 2017

    Grandomics became the largest Oxford Nanopore sequencing center in the world

  • In January 2018

    Grandomics received Nanopore certification service provider qualification, and became the sole in China and one of the first companies in the world to pass the Oxford Nanopore official sequencing service certification

  • In June 2018

    Grandomics formally provides human genome resequencing and bioinformatics services based on the PromethION Platform Worldwide as the first PromthION certification service provider in China

Multiple platforms, multiple combinations More comprehensive, more flexible, more accurate Provide you More discoveries, deeper explorations, broader applications

Copyright © 2015-2018 Beijing Grandomics Biosciences Co.,Ltd ICP-15010265 - Designed By Yanheo